InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
60%
T+90 mean return
-7.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Stankovic Srdjan R., Directeur Comptable. Director active across 1 company, notably Acadia Pharmaceuticals INC. Aggregated, 9 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €48k. History available since 23 February 2022. The latest transaction was filed on 21 November 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
6,250 sharesCommon StockSEC:0001209191-22-058391:0
1,847 shares@ US$15.0755.6% of flowCommon StockSEC:0001209191-22-058391:1
2,969 sharesCommon StockSEC:0001209191-22-054027:0
1,326 shares@ US$15.8144.4% of flowCommon StockSEC:0001209191-22-054027:1
9,616 sharesCommon StockSEC:0001209191-22-026940:0
4,919 shares0Common StockSEC:0001209191-22-013275:0
5,444 sharesCommon StockSEC:0001209191-22-002749:0
6,250 sharesCommon StockSEC:0001209191-21-066570:0
2,969 sharesCommon StockSEC:0001209191-21-060958:0
9 of 9 declarations
About Stankovic Srdjan R.
Christopher G. Lee serves as Chief Accounting Officer at Apria, Inc. In this role, he oversees the company's accounting and financial operations, ensuring compliance and accuracy of financial reporting. Christopher plays a vital role in managing Apria's finances and supporting strategic decisions.
